Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Svahn

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biochemical and Biophysical Research Communications|September 15, 1994
Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptorsS Soker, D Goldstaub, C M Svahn, et al.
Molecular and Cellular Biology|January 1, 1992
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cellsD M Ornitz, A Yayon, J G Flanagan, et al.
Virology|July 1, 1996
Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinaseC X George, D C Thomis, S J McCormack, et al.
The Journal of Biological Chemistry|December 23, 1994
Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptorR Reich-Slotky, D Bonneh-Barkay, E Shaoul, et al.
Science (New York, N.Y.)|April 21, 1995
FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharidesD M Ornitz, A B Herr, M Nilsson, et al.
Nature|July 9, 1998
Structure of a heparin-linked biologically active dimer of fibroblast growth factorA D DiGabriele, I Lax, D I Chen, et al.
Biochemistry|February 25, 1992
Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrixR Ishai-Michaeli, C M Svahn, M Weber, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Modulation of neovascularization and metastasis by species of heparinI Vlodavsky, R Ishai-Michaeli, M Mohsen, et al.
Invasion & Metastasis|January 1, 1994
Inhibition of tumor metastasis by heparanase inhibiting species of heparinI Vlodavsky, M Mohsen, O Lider, et al.
Arzneimittel-Forschung|May 1, 1995
Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparinW Völker, A Böhm, A Schmidt, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|September 15, 1994
Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptorsS Soker, D Goldstaub, C M Svahn, et al.
Molecular and Cellular Biology|January 1, 1992
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cellsD M Ornitz, A Yayon, J G Flanagan, et al.
Virology|July 1, 1996
Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinaseC X George, D C Thomis, S J McCormack, et al.
The Journal of Biological Chemistry|December 23, 1994
Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptorR Reich-Slotky, D Bonneh-Barkay, E Shaoul, et al.
Science (New York, N.Y.)|April 21, 1995
FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharidesD M Ornitz, A B Herr, M Nilsson, et al.
Nature|July 9, 1998
Structure of a heparin-linked biologically active dimer of fibroblast growth factorA D DiGabriele, I Lax, D I Chen, et al.
Biochemistry|February 25, 1992
Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrixR Ishai-Michaeli, C M Svahn, M Weber, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Modulation of neovascularization and metastasis by species of heparinI Vlodavsky, R Ishai-Michaeli, M Mohsen, et al.
Invasion & Metastasis|January 1, 1994
Inhibition of tumor metastasis by heparanase inhibiting species of heparinI Vlodavsky, M Mohsen, O Lider, et al.
Arzneimittel-Forschung|May 1, 1995
Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparinW Völker, A Böhm, A Schmidt, et al.
Pageof 3